A fledgling Twin Cities company that uses Apple technology to gently interrupt the nightmares of those who suffer from post-traumatic stress disorder (PTSD) has begun to commercialize its NightWare product as an economical alternative to drug treatments.
The Food and Drug Administration last week authorized "a new, low-risk treatment option that uses digital technology in an effort to provide temporary relief from sleep disturbance related to nightmares," said Carlos Peña, director of the FDA's Office of Neurological and Physical Medicine Devices.
PTSD is a disorder that affects some who have experienced combat or other shocking or dangerous events.
Though many treatments have been used to help treat PTSD, many involve drugs and some patients experience bad side effects or become dependent on them.
"PTSD is persistent and hard to treat. The less drugs the better," said NightWare CEO Grady Hannah, 47, a St. Paul native who has worked to commercialize NightWare since 2017. "This condition is life-threatening. Suicides."
The company's initial focus will be working with the Department of Veterans Affairs and the Defense Department, he said.
The company said the two departments combined are a $1 billion opportunity for NightWare. The VA spends $3 billion annually on PTSD treatments, not including drugs.
The global PTSD therapeutics market — including drugs — is projected to grow by $900 million from 2020 to 2024, according to Research and Markets.